KalVista Pharmaceuticals’ $58 Million Direct Offering

Foley & Lardner LLP represented TCG Crossover on the deal.TCG Crossover acted as the lead investor in KalVista Pharmaceuticals’ $58 million registered direct offering.   KalVista Pharmaceuticals,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now